3.05
price down icon1.93%   -0.06
after-market 시간 외 거래: 3.02 -0.03 -0.98%
loading
전일 마감가:
$3.11
열려 있는:
$3.12
하루 거래량:
24,732
Relative Volume:
0.06
시가총액:
$9.28M
수익:
-
순이익/손실:
$2.81M
주가수익비율:
-0.2125
EPS:
-14.3497
순현금흐름:
$7.14M
1주 성능:
-3.17%
1개월 성능:
-0.65%
6개월 성능:
-20.37%
1년 성능:
-34.83%
1일 변동 폭
Value
$3.04
$3.13
1주일 범위
Value
$2.96
$3.29
52주 변동 폭
Value
$2.51
$4.80

Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile

Name
명칭
Kiora Pharmaceuticals Inc
Name
전화
781-788-8869
Name
주소
332 ENCINITAS BOULEVARD, ENCINITAS
Name
직원
12
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
KPRX's Discussions on Twitter

KPRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KPRX
Kiora Pharmaceuticals Inc
3.05 9.22M 0 2.81M 7.14M -14.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Kiora Pharmaceuticals Inc 주식(KPRX)의 최신 뉴스

pulisher
Jul 24, 2025

What analysts say about Kiora Pharmaceuticals Inc. stockExceptional risk-adjusted gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Kiora Pharmaceuticals Secures US Patent for KIO-104 - Ophthalmology Times

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Kiora Pharmaceuticals Inc. stock priceConsistent high-performance stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

Is Kiora Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com

Jul 21, 2025
pulisher
Jul 17, 2025

Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com

Jul 16, 2025
pulisher
Jul 15, 2025

How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Kiora Pharmaceuticals Inc. stock price move sharplyPredictable Return Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jun 17, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World

Jun 17, 2025
pulisher
Jun 05, 2025

Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times

Jun 05, 2025
pulisher
Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Oil Prices Climb While US Equity Futures Stutter - Finimize

Jun 04, 2025
pulisher
Jun 04, 2025

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard SurgeMore Stocks Inside! - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 04, 2025

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside! - FinancialContent

Jun 04, 2025
pulisher
Jun 04, 2025

Markets | American Financial Group, Inc. - FinancialContent

Jun 04, 2025
pulisher
Jun 04, 2025

Kiora Pharmaceuticals inks potential $110 million deal with Senju By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize

Jun 03, 2025
pulisher
Jun 03, 2025

Sector Update: Health Care - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Kiora Pharmaceuticals Stock Skyrockets Over 20% in Dynamic Trading Session - Daily Chhattisgarh News

Jun 03, 2025
pulisher
Jun 03, 2025

Traws Pharma Inc. Stock Skyrockets Over 40%, Then Pares Gains in Volatile Trading - Daily Chhattisgarh News

Jun 03, 2025

Kiora Pharmaceuticals Inc (KPRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):